RCPA Pathology Update 2019 Invited Guest International Guest Speakers
The Pathology Update 2019 International Guest Speakers are guests of the Royal College of Pathologists of Australasia and are presenting at the invitation of Pathology Update 2019 Overseeing Committee and Scientific Program Committees. Any enquires about any international guest speakers is requested to go through the RCPA Events and Sponsorship Manager Eve Propper email@example.com or 02 8356 5806.
Dr Thomas Brenn was appointed Professor of Pathology & Laboratory Medicine and Medicine at the Cumming School of Medicine, University of Calgary in 2018. He graduated magna cum laude from the Ruprecht-Karls University of Heidelberg, Germany where he received his MD and PhD degrees. After postdoctoral fellowships in the Departments of Genetics and Pathology at Stanford University Stanford, CA, USA) and residency training in Anatomic Pathology at Brigham and Women’s Hospital ,Boston, USA, he pursued subspecialty fellowships in Dermatopathology, Soft Tissue Tumour Pathology and Surgical Pathology with Drs Phillip McKee and Christopher Fletcher. In 2003, Dr Brenn joined the faculty of the Brigham and Women’s Hospital and Harvard Medical School and was a consultant in pathology at Dana Farber Cancer Institute. From 2007 to 2018, he was Head of Dermatopathology at NHS Lothian University Hospitals Trust and Honorary Senior Lecturer at the University of Edinburgh, Scotland. Dr Brenn is a Diplomate of the American Board of Pathology and Dermatology. He is Associate Editor for Histopathology and was a member of the consensus working group for the 4th edition of the WHO Classification of Tumours of the Skin. He was the Chair of the Skin Working Group of the European Society of Pathology, Chief Examiner for the RCPath Diploma in Dermatopathology and a member of the steering committee of the National Specialist EQA scheme in Dermatopathology and the executive committee of the British Society for Dermatopathology. He has contributed to major textbooks in Dermatology and Dermatopathology and is a co-editor of the 4th edition of McKee’s Pathology of the Skin.
Dr Thomas Brenn is presenting in the Anatomical Pathology scientific stream.
Professor Daniel Chan is a Professor of Pathology, Oncology, Radiology and Urology at the Johns Hopkins University, Baltimore, Maryland, USA. He is a diplomat of the American Board of Clinical Chemistry and a fellow of the National Academy of Clinical Biochemistry. At the Johns Hopkins Hospital, he is the Director of Clinical Chemistry Division and the Co-Director of Pathology Core Laboratories. Professor Chan is the Director and Founder of the JHU Centre for Biomarker Discovery and Translation. He developed the OVA1 test for ovarian cancer using 5 proteins discovered by mass spectrometry. In 2009, OVA1 became the 1st US FDA cleared proteomic in vitro diagnostic multivariate index assay. For the last 10 years, Professor Chan has been the principal investigator of the Biomarker Reference Laboratory for the National Cancer Institute (NCI) Early Detection Research Network as well as the PI of the NCI Clinical Proteomic Tumour Analysis Consortium. The focus of the research is to better understand the molecular basis of cancer through the application of mass spectrometry for global proteomic and post-translational modifications analyses. Professor Chan was a founder and the Chair of the American Association for Clinical Chemistry Proteomics Division. He was a founder and served on the Board of Directors of the USHUPO Human Proteomics Organisation. He is the Editor-in-Chief of Clinical Proteomics, an open access journal BioMed Central focusing on translational proteomics. He has written 5 books, 40 book chapters and >300 scientific articles. Professor Chan received over 20 awards from many scientific organizations in recognition for his contribution to Science including the Outstanding Research Award from the AACC. At the 2014 HUPO world congress in Madrid, Spain, he was awarded the inaugural Translational Proteomics Award for his outstanding life time achievement in proteomics.
Professor Daniel W Chan is presenting David Rothfield Memorial Oration and Chemical Pathology.
Dr Tom Chiller is the Chief of the Mycotic Diseases Branch. As Branch Chief, Dr Chiller provides leadership and support for fungal disease activities nationally and internationally. With over 25 years of experience in global health, Dr Chiller also serves as the Associate Director for Global Programs in the Division of Foodborne, Waterborne, and Environmental Diseases Previously, Dr Chiller has held numerous positions in DFWED including Associate Director for Epidemiologic Science and lead of the National Antimicrobial Resistance Monitoring System for Enteric Bacteria. He remains actively involved in antimicrobial resistance activities for fungal and enteric diseases. Dr Chiller is board certified in infectious diseases and is a faculty member in the Division of Infectious Diseases at the Emory School of Medicine. He practices infectious diseases at the Veterans Affairs Hospital in Atlanta. He has authored numerous articles and book chapters and given many lectures on public health surveillance and infectious diseases. During his past decade with the Mycotic Diseases Branch, Dr Chiller has fostered strong international collaborations and helped to drive forward fungal public health programs in sub-Saharan Africa, Latin America and Southeast Asia. Tom is board certified in infectious diseases and is a faculty member in the Division of Infectious Diseases at the Emory School of Medicine. He practices infectious diseases at the Veterans Affairs Hospital in Atlanta. He has authored numerous articles and book chapters and given many lectures on public health surveillance and infectious diseases.
Dr Tom Chiller is presenting in the Microbiology scientific stream.
A/Professor Obi Griffith is Assistant Professor of Medicine and Assistant Director of the McDonnell Genome Institute at Washington University. He received his PhD in Medical Genetics from the University of British Columbia and completed postdoctoral fellowships at the BC Cancer Agency and Lawrence Berkeley National Laboratories. Dr Griffith’s research is focused on the development of personalized medicine strategies for cancer. Specifically, he develops bioinformatics tools and methods for the analysis of high throughput sequence data and identification of biomarkers for diagnostic, prognostic and drug response prediction. He developed methods and performed analyses for some of the first cancer patients to have whole genome and transcriptome sequencing performed with the goal of identifying personalized treatment options. He is also a strong advocate for open-source and open-access science. Most recently he lead the development of public databases and web tools for cataloguing the druggable genome and expert-crowd-annotation of clinically actionable variants in cancer. A/Prof Griffith’s has published over 85 studies and received numerous research awards and honours including from UBC, Michael Smith Foundation for Health Research, Canadian Institutes of Health Research, BCCA and the US National Academy of Sciences. He was profiled in Maclean’s magazine as one of Canada’s 25 ‘Best and Brightest’ for his contribution to the sequencing of the SARS virus genome, as an ‘up and coming’ investigator in Genome Technology Magazine and in Wired Magazine’s Annual ‘Smart List’. He has held several large grants from the NIH including a K22 Transition Career Development Award and U01 for Development of Informatics Technologies for Cancer Research. He has made substantial contributions to training the next generation of bioinformatics scientists having mentored more than 30 undergraduate, graduate and postdoctoral trainees and taught hundreds more as instructor for Cold Spring Harbor Laboratories, Canadian Bioinformatics Workshops, and online.
A/Professor Obi Griffith is presenting an Innovations Plenary & in the Genetic Pathology scientific stream.
Dr John Hart graduated from the University of Iowa Medical School in 1986. He did his pathology residency at U.C.L.A. Medical Centre, followed by a Gastrointestinal and Hepatic Pathology fellowship at the same institution. In 1991 he joined the faculty of the University of Chicago Department of Pathology as an assistant professor, and rose to the rank of full professor in 2004. He is the chief of the Gastrointestinal and Hepatology Pathology section and director of the fellowship program. The fellowship has graduated more than a dozen GI pathologists who are now working in academic pathology departments throughout the United States and Canada. Dr Hart has published more than 180 articles in the fields of gastrointestinal and hepatic pathology and has also authored numerous book chapters. He has lectured throughout the United States and in Europe and Asia. He currently is a member of the Board of Directors of the United States and Canadian Academy of Pathology and the vice president of the Rodger Haggitt Gastrointestinal Pathology Society. He is a co-author of the upcoming non-neoplastic liver pathology AFIP fascicle to be published by ARP Press.
Dr John Hart is presenting in the Anatomical Pathology scientific stream.
Dr Elaine Jaffe did her medical studies at Cornell University Medical College and the University of Pennsylvania. She has been Chief of the Hematopathology Section at the NCI since 1980. Dr Jaffe is an author of more than 600 peer reviewed articles, 150 chapters and invited reviews and 38 Editorials. She is an Editor for the WHO Classification of Tumours of the Hematopoietic and Lymphoid Tissues, and one of four Series Editors for the 4th Edition of the WHO monographs. Science Watch named her among the 10 most highly cited researchers in clinical oncology, and she was included among the 400 most highly cited researchers in Biomedical Science worldwide between 1996 and 2011. Dr Jaffe has held leadership positions in several major medical societies, including the American Society of Haematology, United States and Canadian Academy of Pathology and the Society for Hematopathology. Dr Jaffe has served on 18 journal editorial boards. In 2008 she was elected to the Institute of Medicine of the National Academies (now the National Academy of Medicine. Among her awards are the Fred W. Stewart Award from Memorial-Sloan Kettering Cancer Centre, the Lennert prize from the European Association for Haematopathology, the Maude Abbott Lecturer for the United States and Canadian Academy of Pathology, the Stratton medal from the American Society of Haematology, and most recently the Rous Whipple Award from the American Society of Investigative Pathology. Dr Jaffe was invited to give the Henry Rappaport Memorial Lecture at the Lugano International Congress on Malignant Lymphoma in 2013. Dr Jaffe was awarded an honorary degree Honoris Causa from the University of Barcelona, and received the Distinguished Graduate Award from the University of Pennsylvania School of Medicine
Dr Elaine Jaffe will present in the combined Anatomical, Haematology and Immunopathology combined scientific stream.
Dr Yulia Lin is the Interim Director of the Blood & Tissue Bank at Sunnybrook Health Sciences Centre and an Associate Professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto. She is a member of provincial and national working groups in transfusion medicine including the Ontario Transfusion Coordinators Network Steering Committee, the Ontario Transfusion Quality Improvement Plan Committee and the Canadian Standards Association Technical Committee on Blood and Blood Products. She is Chair of the University of Toronto Transfusion Camp, a national transfusion medicine education initiative for postgraduate trainees. Her academic interests include quality improvement in patient blood management, transfusion safety and physician education in transfusion medicine.
Dr Yulia Lin will present in the Haematology scientific stream.
Dr Thomas Ruder is a consultant radiologist at the Northland District Health Board Hospital in Whangarei, New Zealand. Prior to his engagement in New Zealand, he was a consultant in emergency radiology at the University Hospital in Bern, Switzerland and a consultant in forensic radiology for the Virtopsy team at the University of Zurich, Switzerland for several years. Dr Ruder has been involved in forensic radiology for more than a decade. He has co-authored over 100 articles on post-mortem and forensic radiology, contributed to several books on forensic imaging, and published two volumes of poetry. In 2013 he completed a habilitation treatise on post-mortem MR and CT. For this achievement he was appointed as lecturer at the University of Zurich in 2015. Thomas Ruder is an experienced speaker with over 180 presentations in the field of forensic imaging and emergency radiology to his credit. He is a regular teacher to the medical professions and was a Virtopsy Course instructor between 2010 and 2017. Dr Ruder is a founder board member and former secretary of the International Society of Forensic Radiology and Imaging (ISFRI). He organized both the first and second ISFRI congress in 2011 and 2012. Thomas Ruder is a co-founder and Associate Editor of the Journal of Forensic Radiology and Imaging and an active reviewer for several forensic and radiologic journals.
Dr Thomas Ruder will present in the Forensic Pathology scientific stream
Dr Sverre Sandberg is a specialist in laboratory medicine. He is director of NOKLUS, a Norwegian organisation for quality improvement of laboratory activity which serves about 80 hospital laboratories and about 3000 users of POC equipment outside hospitals (GP offices, nursing homes, oil platforms etc), chair of SKUP, Scandinavian Evaluation of Laboratory Equipment for Primary Health Care (ww.skup.nu) and director of the Norwegian Diabetes Registry. He is director of the Norwegian Porphyria Centre (NAPOS) (www.napos.no). He is professor at the Institute of Global Health and Primary Health Care at the University of Bergen. From 2002 – 2012 he was director of Laboratory of Clinical Biochemistry at Haukeland University Hospital in Bergen. He was from 1996 – 2002 chair of the Committee on Evidence-Based Laboratory Medicine and from 2002 – 2008 chair of The Global Campaign of Diabetes Mellitus in the International Federation of Clinical chemistry and Laboratory Medicine. Since 2000 he has been a board member of the European Porphyria Network, a partly EU-funded project. From 2012-14 he was president of the European Organization for External Quality Assurance in Laboratory Medicine. In 2009 -2014 he was chair of the Scientific Committee in European Federation of Clinical Chemistry and Laboratory Medicine. From 2014-15 he was vice president and from 2016 president of EFLM. He is chair or member of different working groups in EFLM and IFCC.He has written peer reviewed papers and given international lectures in his fields of interests: evidence based laboratory medicine, quality improvement of point of care instruments, biological variation, performance specifications in laboratory medicine, quality assurance of the total testing process, laboratory aspects of diabetes, porphyria and photobiology. He has supervised numerous PhD students.
Dr Sverre Sandberg will present in the Chemical Pathology and Immunopathology scientific stream.
Dr Lillian Siu is a senior medical oncologist at Princess Margaret Cancer Centre since 1998, and has been a Professor of Medicine at the University of Toronto since 2009. She is the Director of the Phase I Program and Co-Director of the Bras and Family Drug Development Program at Princess Margaret Cancer Centre, and holds the BMO Chair in Precision Genomics from 2016 to 2026. She is also the Clinical Lead for the Tumour Immunotherapy Program at Princess Margaret Cancer Centre. Dr Siu served on the Board of Directors for the American Society of Clinical Oncology for a four-year term 2012-2016. She also served as a member of the Nomination Committee for the American Association for Cancer Research from 2014-2016. She currently serves on the AACR Board of Directors for a three-year term). Dr Siu’s major research focus is in the area of new anticancer drug development, particularly with respect to phase I trials and head and neck malignancies. She is the Principal Investigator of a phase I cooperative agreement UM1 award 2014-2019 sponsored by the United States National Cancer Institute. IIn addition to her active research in early phase clinical trials, she has been leading genomics initiatives and immuno-oncology trials at the Princess Margaret Cancer Centre. Together, the three programs of drug development, cancer genomics and tumour immunotherapy form a triad of synergy that supports the institution’s core vision to deliver precision cancer medicine. Internationally, Dr Siu was the recipient of the US NCI Michaele C. Christian Award in Oncology Drug Development in 2010. Locally, she was awarded the University of Toronto Department of Medicine Eaton Scholar Researcher in 2016. She was the ASCO Conquer Cancer Foundation Grants Selection Committee Chair in 2009-10. She was Chairperson of the AACR Education Committee, Co-Chairperson of the Scientific Committee for the 2012 Annual Meeting and Co-Chairperson for the Clinical Trials Committee 2015-2017. Dr Siu has published over 240 peer-reviewed manuscripts, and she is currently a scientific editor for Cancer Discovery and is on the editorial board for JAMA Oncology.
Dr Lillian Siu will present the Eva Raik Plenary and in the Genetic Pathology scientific stream.
Professor Kathryn Wood is a Professor of Immunology Emerita in the Nuffield Department of Surgical Sciences, University of Oxford where she runs the Transplantation Research Immunology Group Her research focuses on tolerance induction at the molecular and cellular level, immune regulation and interactions between the immune system and stem cell derived tissues. Professor Wood is a Fellow of The Academy of Medical Sciences and is currently the Khoo Oon Teik Visiting Professor at the National University Centre for Organ Transplantation, National University Hospital in Singapore 2015 – 2020. She has a strong interest in providing support and opportunities for the development of scientists, both men and women, to enable them to achieve their full potential and to this end, was instrumental in setting up the New Key Opinion Leaders meetings within TTS and was the founding Chair of the Women in Transplantation initiative. Her research achievements have been recognised internationally, including receiving a Gold Medal awarded by The Catalan Society of Transplantation 2011, The Maharshi Sushruta Award 2012, the Federal Prize 2014, the TTS Women in Transplantation, Achievement Award 2014 and the Thomas E Starzl Prize in Surgery and Immunology 2017. Kathryn was President of The Transplantation Society 2004-2006 and Editor of the Transplantation journal 1992 - 2014.
Professor Kathryn Wood will present in the Immunopathology scientific stream.